Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hand robot brings stroke rehab home: could telerehabilitation boost recovery?

NCT ID NCT07698067

Disease control Sponsor: Dr. Rosalie Wang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial tests whether a wearable hand robot, used at home with remote therapist support, is a feasible way to deliver intensive hand therapy to people who had a stroke at least six months ago. Participants will either use the robot for 12 weeks or receive the same amount of standard therapy without the robot. The study focuses on how well people stick with the program, how safe and reliable the robot is, and the costs compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wearable hand robot (WEAR-IT) with telerehabilitation program
What this could lead to
If successful, this could provide a practical, high-dose hand therapy option for stroke survivors to use at home, potentially improving recovery and reducing the need for clinic visits.
What could go wrong
This is a small feasibility study, not a large efficacy trial, so results may not confirm clinical benefit. The robot may be difficult to use or may not work for all levels of hand impairment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 44 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Each participant must meet all of the following inclusion criteria to participate in this study: A) Persons with chronic stroke: 1. Be able to attend one rehabilitation site (Toronto or Edmonton), 2. Be 18 years of age or older, 3. Be able to provide informed consent, 4. Has English language proficiency, 5. Be in the chronic stage of recovery (e.g., \> 6 months post-stroke), 6. Have hand recovery at Stage 1 (flaccid paralysis) to Stage 4 (inability to make a fist and then extend the fingers fully) on the Chedoke-McMaster Stroke Assessment (CMSA) 7. Have a pain rating between 0/10 (no pain) and 4/10 (moderate pain) at rest and with assisted hand movement 8. Demonstrate the ability to understand and participate in a 3-month study program, 9. Live with someone or have someone consistently available (caregiver participant) who can help with setting up telerehabilitation equipment and assist with putting on/removing the Glove (as needed), and 10. Have access to a computer or tablet with a camera and a reliable internet connection for telerehabilitation sessions. B) Caregiver participants who are willing to assist people living with stroke can be included if they meet the following criteria: 1. Be 18 years of age or older, 2. Be able to provide informed consent , and 3. Be able to support glove donning/doffing, set-up, and therapy for people living with stroke at home. Exclusion Criteria: * All participants meeting any of the following exclusion criteria at baseline will be excluded from participation in this study: A) Persons with chronic stroke: 1. Have no limitations in fully extending fingers or making a fist, 2. Are experiencing pain or cognitive impairments that prevent active participation in therapy, 3. Be unable to communicate with therapists independently, 4. Have had any musculoskeletal or other neurological conditions that would impact their participation in a hand rehabilitation program, or 5. Are currently involved in another rehabilitation program aimed at improving upper limb movement.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke (6 months or more after onset) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke (6 months or more after onset)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Glenrose Rehabilitation Hospital

    Edmonton, Alberta, T5G 0B7, Canada

  • Sunnybrook - St. John's Rehab

    Toronto, Ontario, M2M 2G1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.